Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E David

Showing results (1141-1150 of 1,174) with videos related to

Pageof 118
Sort By:
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The New England Journal of Medicine|May 23, 2012
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopyRobert E Schoen, Paul F Pinsky, Joel L Weissfeld, et al.
Nature Medicine|May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim resultsJeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.
JAMA|October 28, 2011
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trialMartin M Oken, Willam G Hocking, Paul A Kvale, et al.
Cancer Research|March 4, 2010
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancerStella Koutros, Fredrick R Schumacher, Richard B Hayes, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesionsM Haas, B Sis, L C Racusen, et al.
BJU International|November 28, 2008
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trialRobert L Grubb, Paul F Pinsky, Robert T Greenlee, et al.
The New England Journal of Medicine|December 19, 2003
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasiaJohn D McConnell, Claus G Roehrborn, Oliver M Bautista, et al.
Pageof 118

Showing results (1141-1150 of 1,174) with videos related to

Sort By:
Pageof 118
The New England Journal of Medicine|March 20, 2009
Mortality results from a randomized prostate-cancer screening trialGerald L Andriole, E David Crawford, Robert L Grubb, et al.
Journal of the National Cancer Institute|January 10, 2012
Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-upGerald L Andriole, E David Crawford, Robert L Grubb, et al.
JCO Oncology Practice|December 19, 2024
Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is NowNeal Shore, Sarah M Nielsen, Edward D Esplin, et al.
The New England Journal of Medicine|May 23, 2012
Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopyRobert E Schoen, Paul F Pinsky, Joel L Weissfeld, et al.
Nature Medicine|May 14, 2024
Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim resultsJeffrey Sevigny, Olga Uspenskaya, Laura Dean Heckman, et al.
JAMA|October 28, 2011
Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trialMartin M Oken, Willam G Hocking, Paul A Kvale, et al.
Cancer Research|March 4, 2010
Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancerStella Koutros, Fredrick R Schumacher, Richard B Hayes, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 30, 2014
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesionsM Haas, B Sis, L C Racusen, et al.
BJU International|November 28, 2008
Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trialRobert L Grubb, Paul F Pinsky, Robert T Greenlee, et al.
The New England Journal of Medicine|December 19, 2003
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasiaJohn D McConnell, Claus G Roehrborn, Oliver M Bautista, et al.
Pageof 118